Overview

  • Product name
    Salsolinol hydrochloride
  • Description
    Dopamine derivative
  • Biological description
    Dopamine (ab120565) derivative. Putative endogenous opioid system-activating factor. Antagonizes L-DOPA-mediated hyperactivity. Shows central effects in vivo.
  • Purity
    > 99%

Properties

References

This product has been referenced in:
  • Mozdzen E  et al. Salsolinol, an endogenous compound triggers a two-phase opposing action in the central nervous system. Neurotox Res 27:300-13 (2015). Read more (PubMed: 25537852) »
  • Wasik A  et al. Chronic Salsolinol Administration Prevents the Behavioral and Neurochemical Effects of L-DOPA in Rats. Neurotox Res 27:399-410 (2015). Read more (PubMed: 25711629) »
  • Zhu W  et al. Effect of (R)-salsolinol and N-methyl-(R)-salsolinol on the balance impairment between dopamine and acetylcholine in rat brain: involvement in pathogenesis of Parkinson disease. Clin Chem 54:705-12 (2008). Read more (PubMed: 18238832) »
  • Mravec B Salsolinol, a derivate of dopamine, is a possible modulator of catecholaminergic transmission: a review of recent developments. Physiol Res 55:353-64 (2006). Read more (PubMed: 16238467) »
  • Naoi M  et al. Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains. Neurotoxicology 25:193-204 (2004). Read more (PubMed: 14697894) »
  • Matsuzawa S  et al. Involvement of mu-opioid receptor in the salsolinol-associated place preference in rats exposed to conditioned fear stress. Alcohol Clin Exp Res 24:366-72 (2000). Read more (PubMed: 10776678) »

See 0 Publications for this product

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab120603.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"

Sign up